Dengue viruses (DENVs) are single-stranded RNA viruses belonging to the family Flaviviridae. There are four distinct antigenically related serotypes, DENVs types 1, 2, 3, and 4. These are all mosquito-borne human pathogens. Congenital dengue disease occurs when there is mother-to-fetus transmission of the virus and should be suspected in endemic regions in neonates presenting with fever, maculopapular rash, and thrombocytopenia. Although most of the infected infants remain asymptomatic, some can develop clinical manifestations such as sepsis-like illness, gastric bleeding, circulatory failure, and death. Neurological manifestations include intracerebral hemorrhages, neurological malformations, and acute focal/disseminated encephalitis/encephalomyelitis. Dengue NS1Ag, a highly conserved glycoprotein, can help the detection of cases in the viremic stage. We do not have proven specific therapies yet; management is largely supportive and is focused on close monitoring and maintaining adequate intravascular volume.
Keyphrases
- dengue virus
- aedes aegypti
- zika virus
- endothelial cells
- liver failure
- extracorporeal membrane oxygenation
- coronary artery
- pregnant women
- quantum dots
- respiratory failure
- binding protein
- septic shock
- pulmonary embolism
- highly efficient
- gram negative
- nucleic acid
- loop mediated isothermal amplification
- label free
- brain injury
- antimicrobial resistance